I-VET
I-VET operates Italy's largest veterinary reference laboratory network, processing over 2 million diagnostic tests annually for more than 5,000 veterinary clinics across three sites (Brescia, Torino, Latina), and distributes point-of-care analyzers, rapid tests, and AI diagnostic tools alongside scientific consulting from 50+ clinical pathologists. Since January 2026 it has been part of Vimian Group.
- Company typePrivate
- Founded2008
- HeadquartersFlero, Italy
- Headcount11–50
- GTM typeB2B
- OfferingServices
What I-VET does
I-VET S.R.L. is an Italian veterinary diagnostics company headquartered in Flero (Brescia) that operates Italy's largest veterinary reference laboratory network through three operational sites (Brescia, Torino, and Latina). The company serves more than 5,000 active veterinary clinic clients across Italy, processing over 2 million diagnostic tests per year across clinical chemistry, hematology, microbiology, cytology, histology, allergology, genetics, molecular biology, and parasitology. Its portfolio combines centralized reference-laboratory services, point-of-care analyzers (in-clinic biochemistry, hematology, blood gas, urine, and AI-powered fecal analyzers), rapid immunodiagnostic tests, scientific consulting from over 50 board-certified clinical pathologists, and a cloud-based I-VET HUB / Area Riservata digital platform.
I-VET generates revenue across four interconnected streams: professional laboratory services billed per test, hardware sales of in-clinic analyzers (STAR2, MEK 6550K, LASER5, LabX, RAPIDPoint 500e, VG1/VG2, CLINITEK Status+, OvaCyte Pet, and the PreciPoint digital microscope), recurring consumable revenue from rapid tests (FIVEFeLView, FilarView, GiardView, LeishView) and reagents, and bundled technical/scientific support. Distribution is sales-led through 20 field representatives and supplemented by an e-commerce storefront (store.i-vet.it), a client ordering portal, and a BioFleet refrigerated logistics fleet with 15 dedicated couriers plus DHL partnership for outside areas, enabling same-day processing and reporting for more than 80% of samples.
The company has grown through three regional laboratory acquisitions (Elleviti, Bianalisi, VetLab in 2020; ProvetLab in 2022) and joined the publicly listed Vimian Group in January 2026, after which I-VET signed an exclusive Italian distribution agreement with Seamaty in May 2026. It holds ISO 9001:2015 certification, was ranked an FT1000 Leader of Growth 2024 by Financial Times and Il Sole 24 Ore, and operates an ECVM satellite center for veterinary microbiology.
I-VET firmographics
Firmographics- Name
- I-VET
- Legal name
- I-VET S.R.L.
- Website
- https://i-vet.it
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- I-VET operates Italy's largest veterinary reference laboratory network, processing over 2 million diagnostic tests annually for more than 5,000 veterinary clinics across three sites (Brescia, Torino, Latina), and distributes point-of-care analyzers, rapid tests, and AI diagnostic tools alongside scientific consulting from 50+ clinical pathologists. Since January 2026 it has been part of Vimian Group.
- Ownership category
- akta.pro rank
I-VET industry classification
Industry- Product category
- Veterinary Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Veterinary Services (54194)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)
- akta.pro secondary industries
- Veterinary Diagnostic Laboratories & Pathology (AFAEANAF), Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)
Keywords
Where I-VET is headquartered
LocationHeadquarters
- HQ city
- Flero
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
I-VET business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Laboratory Services: Central revenue stream. I-VET operates the largest network of veterinary analysis laboratories in Italy (Brescia, Torino, Latina), processing over 2 million tests per year across specialties including clinical chemistry, hematology, microbiology, cytology, histology, allergology, genetics, and molecular biology. Samples are collected from veterinary clinics via dedicated refrigerated logistics or conventional couriers, with same-day results for most samples.
- Diagnostic Instruments and Analyzers: Sale and distribution of veterinary diagnostic instruments including biochemistry analyzers (Star2, LabX), hematology analyzers (MEK 6550K, Laser5), blood gas analyzers (RAPIDPoint 500e, VG1, VG2), urine analyzers (CLINITEK Status+), and AI-powered fecal analyzers (OvaCyte Pet). Instruments are sold with installation, training, technical support, and consumables supply agreements.
- Rapid Tests and Reagents: Sale of rapid diagnostic tests (FIVEFeLView for FIV/FeLV, FilarView for Dirofilaria, GiardView for Giardia, LeishView for Leishmania) and reagents for proprietary and third-party analyzers. Consumable revenue stream with recurring purchase patterns from installed instrument base and direct rapid test buyers.
- Technical and Scientific Support Services: On-site technical assistance, instrument maintenance, and free scientific consulting provided by a team of over 50 clinical pathologists. Technical support is included with instrument sales and contracts, with consulting available to both clients and non-clients as a competitive differentiator.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
I-VET product offering
Product offeringCore offering
I-VET operates Italy's largest network of veterinary diagnostic laboratories (Brescia, Torino, Latina), processing more than 2 million tests per year across clinical chemistry, hematology, microbiology, cytology, histology, molecular biology, allergology, and genetics for veterinary clinics. The company also distributes point-of-care diagnostic analyzers, rapid immunochromatographic tests, and reagents, and bundles these with consumables, training, technical support, and free scientific consulting from a team of over 50 clinical pathologist veterinarians. An integrated digital platform (I-VET HUB and the Area Riservata client portal) enables electronic sample acceptance, real-time result access, and cloud-based report management, while the BioFleet refrigerated logistics network ensures sample integrity.
Product overview
I-VET is an integrated veterinary diagnostic company operating Italy's largest veterinary laboratory network. The portfolio consists of: (1) Point-of-care analyzers for in-clinic diagnostics including hematology (MEK 6550K, LASER5), biochemistry and coagulation (STAR2), blood gas and electrolytes (RAPIDPoint 500e, VG1, VG2), and the multi-modal LabX 3-in-1 system; (2) AI-powered diagnostic tools including OvaCyte Pet for fecal parasite analysis and PreciPoint Scanner for digital microscopy; (3) Rapid tests (FIVEFeLView, FilarView, GiardView, LeishView); (4) Centralized reference laboratory services with same-day results, temperature-controlled BioFleet logistics, and scientific consulting; (5) Cloud-based digital platform (Online Reserved Area) with I-VET HUB software for results management. The company also distributes Seamaty veterinary diagnostics exclusively in Italy and maintains partnerships with Siemens Healthineers and Nihon Kohden for analyzer technologies.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over 80% of samples collected, processed, and reported same-day
- +4 more outcomes
Companies that use I-VET
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
I-VET technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability4 records
Feature6 records
I-VET partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, minor and supporting.
- SeamatycoreI-VET became the exclusive Italian distributor for Seamaty veterinary diagnostic products. The agreement (signed May 17, 2026) covers distribution of Seamaty analyzers in Italy, sale of reagents, and specialized technical and post-sale support for customers. Alessandro Zamara joined I-VET as Commercial Director as part of this agreement.
- Vimian GroupminorI-VET announced joining Vimian Group in January 2026. Vimian Group is a global veterinary health company, and this acquisition/integration positions I-VET within a larger international veterinary diagnostics network.
- Siemens HealthineerscoreI-VET is an official partner of Siemens Healthineers for the distribution and support of the RAPIDPoint 500e blood gas analyzer in the Italian veterinary market. Siemens Integri-sense technology powers the analyzer, and I-VET provides comprehensive training programs for veterinary clients using the device.
- DHLsupportingDHL serves as the partnered courier for biological sample transport for I-VET clients located outside the direct BioFleet pickup coverage area. Booking is integrated into the I-VET Area Riservata client portal.
- University of Messina (Università degli Studi di Messina)supportingI-VET partnered with the University of Messina's Department of Veterinary Sciences to host an educational event on FIP (Feline Infectious Peritonitis), demonstrating collaboration between private diagnostics and academia for veterinary continuing education.
Scale indicators12 records
Recent moves8 records
Expansion highlights6 records
I-VET competitors and assessment
Company assessmentBroad incumbents
- Sysmex: Leading hematology analyzer manufacturer whose XN-V series is distributed by I-VET in Italy. Comparable as a peer in veterinary hematology diagnostics, and a strategic OEM supplier whose commercial moves materially impact I-VET's offering.
- Mindray Animal Medical: Global manufacturer of veterinary and human IVD analyzers (hematology, biochemistry) competing with I-VET's distributed instrument portfolio. Broader incumbent with manufacturing scale and multi-region distribution.
- Zoetis Diagnostics: Animal health giant whose Vetscan line of in-clinic analyzers and reference lab services compete directly with I-VET's portfolio. Zoetis is a broader incumbent spanning pharma, vaccines, and diagnostics, with greater capital and global reach.
Direct peers
- IDEXX Laboratories: Global leader in companion animal diagnostics, operating reference laboratories plus a broad portfolio of in-clinic analyzers (Catalyst, ProCyte, Snapshot) and rapid tests. Directly comparable to I-VET in combining central lab services, POC instruments, consumables, and software.
- Antech Diagnostics (Mars Petcare): Operates a large veterinary reference laboratory network alongside in-clinic diagnostic instruments, now part of Mars Petcare. Closely matches I-VET's integrated lab-plus-instrument-plus-consumables business model in North America and increasingly in Europe.
- Heska (Mars Petcare): Veterinary diagnostics specialist offering POC analyzers (Element, scil Vet) and rapid tests; acquired by Mars Petcare. Direct competitor in the in-clinic veterinary diagnostics space served by I-VET's instrument distribution arm.
- Laboklin: Germany-based veterinary diagnostic reference laboratory offering clinical chemistry, hematology, microbiology, genetics, and allergy testing across Europe. Closely comparable to I-VET's central lab services model with strong European footprint.
- Agrolabo: Italian veterinary diagnostics laboratory with a broad portfolio of reagents, rapid tests, and lab services for companion animals and livestock. Direct competitor in the Italian reference lab market alongside I-VET.
- Scil Animal Care (scil vet): Italy-headquartered veterinary diagnostics company distributing analyzers (Element, others) and offering lab services. Direct competitor in I-VET's home Italian market with overlapping POC and reference lab offerings.
Regional players
- Evidensia (IVC Evidensia): Major European veterinary care group operating clinics and in-house diagnostics across multiple countries; comparable to I-VET as a customer of reference lab services and as an emerging consolidator with internal diagnostic capabilities in regional European markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
I-VET social profiles
Digital presenceI-VET compliance and trust
Trust signalCompliance2 records
I-VET financial estimates
Financial estimateRevenue estimate
Valuation estimate
I-VET leadership team
Management profileNumber of profiles
Profiles5 records
I-VET subsidiaries and ownership
Company hierarchySubsidiaries4 records
I-VET funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
I-VET M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about I-VET
What does I-VET do?
I-VET operates Italy's largest network of veterinary diagnostic laboratories (Brescia, Torino, Latina), processing more than 2 million tests per year across clinical chemistry, hematology, microbiology, cytology, histology, molecular biology, allergology, and genetics for veterinary clinics. The company also distributes point-of-care diagnostic analyzers, rapid immunochromatographic tests, and reagents, and bundles these with consumables, training, technical support, and free scientific consulting from a team of over 50 clinical pathologist veterinarians. An integrated digital platform (I-VET HUB and the Area Riservata client portal) enables electronic sample acceptance, real-time result access, and cloud-based report management, while the BioFleet refrigerated logistics network ensures sample integrity.
Is I-VET a public or private company?
I-VET is a private company. It is classified as corporate owned and is currently operating.
When was I-VET founded?
I-VET was founded in 2008. It employs 11 to 50 people.
Where is I-VET based?
I-VET is headquartered in Flero, Italy, in the Europe region.
How does I-VET make money?
Four revenue lines are on record. Veterinary Laboratory Services are the primary driver. The others are diagnostic Instruments and Analyzers, rapid Tests and Reagents and technical and Scientific Support Services.
Who are I-VET's main competitors?
Broad incumbents on record are Sysmex, Mindray Animal Medical and Zoetis Diagnostics. Direct peers are IDEXX Laboratories, Antech Diagnostics (Mars Petcare), Heska (Mars Petcare), Laboklin, Agrolabo and Scil Animal Care (scil vet). Evidensia (IVC Evidensia) is listed as a regional player.
Does I-VET have an API?
No public API is recorded for I-VET.
What industry is I-VET in?
I-VET's product category is Veterinary Diagnostics. Its primary akta.pro industry code is HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry), with a secondary code of AFAEANAF, Veterinary Diagnostic Laboratories & Pathology. Its NAICS code is 621511 and its SIC code is 8071.